Analystreport

PDL BioPharma, Inc. (NASDAQ: PDLI) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating.

PDL BIOPHARMA  (PDLI) 
Last pdl biopharma earnings: 3/11 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.pdl.com